Under the influence of the "storm" of meta financial report and the accelerated tightening of monetary policy by major central banks around the world, the three major indexes of US stocks collectively opened low on Thursday, of which the NASDAQ index fell nearly 4%, and meta also set a new record of US $237.5 billion in one-day market value evaporation.
(minute chart of three indexes, source: tradingview)
Matt Maley, chief market strategy analyst at Miller Tabak + said that the market suffered continuous blows today. While meta fell sharply, the policy position of the European Central Bank also began to turn. In the past four trading days, the US stock market has pulled up in the afternoon, so investors had expected a rebound in the afternoon. When this expectation failed, traders also lost a lot of confidence.
It is worth mentioning that after hours on Thursday, Amazon's better than expected earnings triggered a sharp rise in stock prices, which is expected to drive the market sentiment to pick up. In addition, before Friday's trading, the US January non farm report will be released. After the unexpected negative ADP data on Wednesday, the market is also worried about a similar situation in non farm.
market dynamics
As of the close, the S & P 500 index fell 2.44% to 4477.44; The NASDAQ index fell 3.74% to 13878.82; The Dow Jones index fell 1.45% to 35111.16.
From the perspective of industry concept, coking coal, aluminum and other sectors rose ahead, while concepts such as social media and home economy led the decline.
hot stock performance
U.S. technology stocks generally fell sharply, including apple fell 1.67%, Tesla fell 1.60%, Amazon fell 7.81%, Google a fell 3.32%, Netflix fell 5.56%, Microsoft fell 3.90%, Qualcomm fell 4.84%, amd fell 2.18% and NVIDIA fell 5.13%.
The concept of economic restart also fell across the board, with Goldman Sachs down 1.15%, Chevron down 0.89%, ExxonMobil down 1.17%, American Airlines down 2.30%, United Airlines down 2.36%, Delta Airlines down 1.95%, Royal Caribbean cruise down 2.31%, Norwegian Cruise down 3.85% and Boeing down 0.54%.
China concept shares were also not spared on Thursday. In addition to the slight rise of Ali, well-known Internet companies such as jd.com, Netease, futu holdings and Baidu all fell by nearly 2%.
company news
[Amazon's fourth quarter net sales of $137.4 billion and operating profit of $3.5 billion]
Amazon released its fourth quarter report after hours on Thursday, with net sales of $137.4 billion and analysts expected $137.82 billion; The fourth quarter operating profit was US $3.5 billion, with an estimated US $2.43 billion; Earnings per share of US $27.75, estimated at US $3.77; Net sales in the first quarter are expected to reach US $112 billion to US $117 billion; The operating profit in the first quarter is expected to be US $3 billion to US $6 billion, with an estimated US $6.06 billion. Prime members will raise their prices to $139 / year, up from $119 / year. As of press time, Amazon shares rose 17% after hours.
[selab's fourth quarter revenue was $1.3 billion, and analysts expected $1.2 billion]
Social media company snap disclosed its quarterly report after hours on Thursday, of which the adjusted EBITDA in the fourth quarter was $326.8 million, and analysts expected $179.4 million; The number of live users in the four seasons is 319 million, and analysts expect 316 million; Adjusted EPS was $0.22 and analysts expected $0.11, which was the first time in the company's history to achieve a positive profit. As of press time, salad cloth rose 39% after trading, and the company's share price fell 23% on Thursday, dragged down by meta.
[the US Senate Judiciary Committee passed the open application market act]
On Thursday local time, the US Senate Judiciary Committee passed the open application market bill with a result of 20-2, which will be submitted to the whole house for voting. The bill will require apple and Google to allow app developers to use other payment systems in IOS and Android, and allow consumers to install third-party app stores. Both companies objected to this, emphasizing that excessive openness may endanger consumers' privacy and information security.
[MSD expects revenue growth of nearly 20% in 2022, mainly driven by covid-19 oral drug]
On Thursday local time, American pharmaceutical company MSD released its fourth quarter financial report, with a revenue of US $13.52 billion and a net profit of US $4.5 billion, both exceeding market expectations. Mursadong also said that the revenue guidance in 2022 is expected to be US $56.1 billion to US $57.6 billion, an increase of nearly 20% compared with us $48.7 billion last year, of which the annual revenue of covid-19 oral drug monapiravir is about US $5-6 billion, and this drug achieved US $952 million in the fourth quarter of last year.
[tight supply chain combined with declining demand for masks, Honeywell's financial report was lower than expected]
U.S. manufacturing giant Honeywell disclosed on Thursday that the company achieved a revenue of $8.66 billion in the fourth quarter of last year, a slight decline compared with the same period. Among them, the revenue of the safety and productivity solutions department, which produces masks, fell by 10%, while the performance of the aviation department also fell due to rising raw material prices and tight supply chain. Honeywell's revenue guidelines for 2022 were $35.4 billion to $36.4 billion, lower than analysts' expectations of $36.76 billion. As of Thursday's close, Honeywell fell 7%.
[Lilly postpones Alzheimer's new drug approval schedule]
Lilly pharmaceutical announced on Thursday that it would postpone the timetable for completing the rapid approval of donanemab, a new Alzheimer's drug, from the first quarter of this year to "within 2022". The company explained that in the case of relevant new drugs covered by the Federal Health Insurance Co., Ltd., the difference between approval and approval is not big. Previously, the U.S. medical care and medical assistance service center has tightened the coverage policy of Alzheimer's drugs, in which the federal medical insurance only reimburses the new drug aduhelm used in approved clinical trials.
[shipments of Apple mobile phones in India increased by 34% year-on-year]
According to market research firm counterpoint, Apple's mobile phone shipments in India reached 2.3 million units in the fourth quarter of last year, a year-on-year surge of 34%, marking the opening of the consumer electronics giant in India. It is reported that Xiaomi (9.3 million units) and Samsung (7.2 million units) are still the brands with the largest shipments in the Indian market.
